US Corporate Board Director Changes SEC Filings — May 04, 2026

04-05-2026

On May 4, 2026, Steve Odland informed General Mills, Inc. that he will not stand for reelection to the Board of Directors at the 2026 Annual Meeting of Shareholders in September, after more than 20 years of service. Mr. Odland will continue serving through the remainder of his current term. This is a planned transition with no abrupt departure or other changes disclosed.

• ·Annual Meeting of Shareholders scheduled for September 2026

04-05-2026

Great Elm Capital Corp. (GECC) reported Q1 2026 NII of $5.0 million ($0.36 per share), up approximately 13% QoQ from $4.4 million ($0.31 per share), supported by a $2.8 million incentive fee waiver, while total investment income declined to $9.5 million from $12.6 million QoQ and NAV dropped to $7.74 per share ($107.5 million) from $8.07 ($112.9 million) due to $5.7 million in net unrealized losses. The Board appointed Jason Reese as CEO effective May 4, 2026, called or repurchased all $57.5 million GECCO notes due June 2026, repurchased ~1% of shares (0.1 million) for $0.5 million at a 36% discount to NAV, and declared a $0.25 per share Q2 dividend yielding 18% annualized on May 1 closing price. Liquidity is strong with ~$10 million cash/equivalents, $50 million revolver availability, and asset coverage at 161.8%.

• ·Less than 1% of investments on nonaccrual as of March 31 2026
• ·Asset coverage ratio 161.8% as of March 31 2026 (vs 158.1% Dec 31 2025)
• ·GECM waives all incentive fees through June 30 2026
• ·$1.2 million additional distribution from CoreWeave post quarter-end
• ·$9.5 million remaining capacity under share repurchase program
• ·Conference call scheduled May 5 2026 at 8:30 AM ET

04-05-2026

Aura Biosciences appointed Natalie Holles as Chief Executive Officer, President, and Board member effective April 30, 2026, succeeding founder Elisabet de los Pinos, Ph.D., who stepped down from her roles. The Phase 3 CoMpass trial for belzupacap sarotalocan (bel-sar) in early choroidal melanoma has enrolled 86 patients as of May 4, 2026, with over 25 additional patients scheduled or identified for screening through May 2026, on track for enrollment completion by mid-2026 and topline data in the second half of 2027. No declines or flat performance metrics were reported.

• ·CoMpass trial is under Special Protocol Assessment agreement with FDA and has Orphan Drug Designation from FDA and EMA, plus Fast Track designation from FDA.
• ·Natalie Holles has over 25 years of experience, including prior CEO roles at Third Harmonic Bio and Audentes Therapeutics.

04-05-2026

George Furlan resigned as Director and Interim Chief Executive Officer effective April 24, 2026, with the resignation accepted by the Board on May 1, 2026, and no disagreements on company operations, policies, or practices. The Board, now consisting of Eric Bruns (Chairman) and Dionne Harvey Pendleton, designated Serge Knazev (President and COO since January 1, 2026) as Acting Principal Executive Officer effective May 1, 2026, pending searches for a permanent CEO and new director. Compensation owed to Mr. Furlan for periods ended December 31, 2025, and March 31, 2026, is under review, with no separation agreement entered as of the filing date.

• ·Resignation informed telephonically on April 24, 2026; written notice received April 29, 2026.
• ·Company will amend this 8-K within four business days if material separation terms are determined for Mr. Furlan.

04-05-2026

Apellis Pharmaceuticals, Inc. amended and restated its Executive Separation Benefits and Retention Plan (A&R Separation Benefits Plan) effective upon the closing of its merger with Biogen Inc., as per the Merger Agreement. The amendments accelerate vesting of Converted Options and Converted RSU Awards for participants, including named executive officers, upon termination without cause or resignation for good reason, and modify the 'Good Reason' definition for C-Level Officers to not exclude changes due to becoming a subsidiary. No financial impacts or performance metrics are disclosed in the filing.

• ·Amendments apply to all participants including named executive officers.
• ·Plan effective on Closing Date of Merger Agreement.
• ·Date of earliest event: April 28, 2026; Filing Date: May 4, 2026.

04-05-2026

At the annual stockholder meeting on April 30, 2026, Intuitive Surgical's shareholders elected all ten Board nominees with overwhelming support (e.g., David J. Rosa received 282,229,466 For votes), approved the advisory say-on-pay for named executive officers (265,030,878 For), ratified PricewaterhouseCoopers LLP as independent auditors (308,789,950 For), and approved the Amended 2010 Incentive Award Plan, increasing shares reserved from 120,350,000 to 125,350,000 and extending the term to January 29, 2036. The Board also increased the common stock repurchase program authorization to an aggregate of $5.0 billion. All proposals passed decisively with minimal opposition.

• ·Proposal 2 Against votes: 17,018,702
• ·Proposal 4 Against votes: 22,129,032 (highest opposition among proposals)

04-05-2026

Valion Bio, Inc. (formerly Tivic Health Systems, Inc., Nasdaq: VBIO), a clinical-stage immunotherapeutics company, announced the appointment of Melinda Lackey as General Counsel and Senior Vice President of Legal Affairs on May 4, 2026. Ms. Lackey brings nearly two decades of experience in biopharmaceutical legal matters, IP strategy, and Nasdaq governance from roles at Alaunos Therapeutics, Kuur Therapeutics, and firms like Winston & Strawn LLP. The hire supports advancing Entolimod™ toward FDA Animal Rule approval for Acute Radiation Syndrome, scaling CDMO subsidiary Velocity Bioworks, and executing capital raises.

• ·Entolimod™ has received Fast Track and Orphan Drug designations from the FDA.
• ·Ms. Lackey's early career included roles as Research Associate at University of Texas Health Science Center at Houston and Research Technician at UT MD Anderson Cancer Center.
• ·J.D. from University of Houston Law Center.
• ·Investor contact: Rich Cockrell, CG Capital.

04-05-2026

Damora Therapeutics, Inc. announced on April 28, 2026, that Chief Financial Officer Lori Firmani will depart effective May 1, 2026, receiving separation benefits including a $6,000 health savings account contribution, base salary continuation and pro-rated target bonus in a lump sum, and full acceleration of equity awards, subject to a release agreement. The Board appointed Brian Burkavage, current Senior Vice President of Finance, as the new principal financial officer and principal accounting officer effective the same date. No arrangements, family relationships, or material transactions involving Mr. Burkavage were disclosed.

• ·Lori Firmani served as principal financial officer and principal accounting officer since August 2024, prior to the Company's acquisition of privately-held Damora Therapeutics, Inc. in November 2025.
• ·Brian Burkavage joined the Company in December 2025 after serving as SVP Finance and Chief Accounting Officer at IO Biotech, Inc. (November 2021 to December 2025), Controller at Passage Bio, Inc. (2020-2021), Director of Financial Planning and Analysis at Aclaris Therapeutics, Inc. (2017-2020), and 11 years at Ernst & Young LLP.
• ·Separation benefits described in the Company's Definitive Proxy Statement on Schedule 14A filed April 28, 2026.
• ·Mr. Burkavage to enter standard indemnification agreement for executive officers.

04-05-2026

Hercules Capital, Inc. (NYSE: HTGC) announced the promotion of Seth Meyer from CFO to President effective May 18, 2026, to oversee platform scaling and growth. Andrew Olson, a returning executive with 19 years of experience, was appointed as the new CFO and Head of Corporate Development on the same date. CEO Scott Bluestein highlighted the moves as strategic for accelerating growth and maintaining financial strength.

• ·Hercules common stock trades on NYSE under ticker HTGC.
• ·Andrew Olson previously served at Hercules from 2014 to 2017 in finance roles including Interim CFO.
• ·Seth Meyer has served as CFO since 2019.

04-05-2026

Effective April 28, 2026, Richard Akright resigned as Co-Chief Financial Officer of urban-gro, Inc., with the resignation not due to any disagreement on operations, policies, or accounting matters. Eric Sherb, previously the other Co-Chief Financial Officer, will now serve as the sole Chief Financial Officer. The 8-K was filed on May 4, 2026, and signed by Bradley Nattrass, Chairman and Chief Executive Officer.

• ·Company address: 1751 Panorama Point, Unit G, Lafayette, CO 80026
• ·Trading symbol: UGRO (Common Stock, par value $0.001 per share)

04-05-2026

Madison Square Garden Sports Corp. appointed Paul DiCicco, aged 51 with prior CFO experience at Stephen Gould Corporation and roles at Harris Blitzer Sports and Entertainment LLC, as Executive Vice President, Chief Financial Officer, and Treasurer effective May 11,

04-05-2026

Exxon Mobil Corporation announced on April 28, 2026, that Len M. Fox, Vice President, Controller and Tax (principal accounting officer), intends to retire effective July 1, 2026. The company simultaneously elected Susan Buchanan, age 44, as Vice President and Chief Accounting Officer (principal accounting officer) and Controller, effective July 1, 2026. Ms. Buchanan has held prior roles including President of ExxonMobil Global Business Solutions since February 2026.

• ·Susan Buchanan previously served as Vice President, Strategy and Business Development for ExxonMobil Upstream from October 2023 to February 2026.
• ·She was General Manager of the U.S. Conventional Upstream Business from November 2022 to October 2023.
• ·Prior roles include Manager, Upstream Strategy from April 2021 and positions in Treasurers and Controllers functions.
• ·Ms. Buchanan, like other executive officers, does not have an employment contract.
• ·Filing signed by Neil A. Hansen on May 4, 2026.

04-05-2026

Sonos reported Q2 FY2026 revenue of $282 million, up 8% YoY from $260 million, with Adjusted EBITDA improving to $2 million from a $1 million loss, marking the first positive Q2 Adjusted EBITDA in four years. First half FY2026 revenue increased 2% YoY to $827 million, while Adjusted EBITDA rose 48% YoY to $134 million and GAAP gross margin improved to 45.7%. However, Q2 GAAP net loss was $29 million despite a $41 million YoY improvement, and Non-GAAP net loss was $3 million.

• ·Cash and cash equivalents increased to $200 million from $175 million at FY end.
• ·Operating cash flow for H1 FY2026 was $98 million, slightly up from $97 million YoY.
• ·Shareholders' equity rose to $384 million from $355 million at FY end.
• ·Ongoing IP litigation expenses against Alphabet and Google classified as non-GAAP adjustments.

04-05-2026

The Brink’s Company held its 2026 Annual Meeting on April 28, 2026, where shareholders elected nine directors to the Board for terms expiring in 2027, approved an advisory resolution on named executive compensation, ratified KPMG LLP as independent auditors for the fiscal year ending December 31, 2026, and approved the Amended and Restated 2024 Equity Incentive Plan adding 3,900,000 shares of common stock. A shareholder proposal requesting a report on employee retention rates by demographic categories was overwhelmingly rejected. All company proposals received strong shareholder support with minimal opposition.

• ·Proposal 1 (Director Elections): For votes ranged from 33,968,237 (Kathie J. Andrade) to 36,098,041 (Timothy J. Tynan); Against ranged from 264,874 to 2,281,591.
• ·Proposal 2 (Say-on-Pay): 35,902,479 For, 419,407 Against.
• ·Proposal 3 (Auditor Ratification): 38,023,925 For, 70,920 Against.
• ·Proposal 4 (Equity Plan): 35,301,445 For, 1,018,331 Against.
• ·Proposal 5 (Shareholder Proposal): 2,619,075 For, 33,439,945 Against.

04-05-2026

Ingevity Corporation held its Annual Meeting of Stockholders on April 29, 2026, where shareholders elected all nine director nominees with overwhelming support (over 95% FOR votes for most, ranging from 96.8% to 99.0%). Stockholders also approved the amendment to the 2025 Omnibus Incentive Plan increasing available shares by 580,000 (97.0% FOR), ratified PricewaterhouseCoopers LLP as auditors for fiscal 2026 (99.6% FOR), and approved named executive officer compensation on an advisory basis (89.3% FOR), with a quorum of 95.10% of 35,222,538 shares outstanding.

• ·Detailed director voting: Luis Fernandez-Moreno (31,173,836 FOR, 862,109 WITHHELD); Diane H. Gulyas (31,183,123 FOR, 852,804 WITHHELD); all others similarly high FOR votes with minimal opposition.
• ·Executive compensation vote: 28,593,615 FOR, 3,435,921 AGAINST, 25,712 ABSTAIN, 1,443,084 broker non-votes.
• ·Auditor ratification: 33,358,881 FOR, 118,571 AGAINST, 20,880 ABSTAIN.
• ·Plan amendment: 31,038,374 FOR, 990,650 AGAINST, 26,224 ABSTAIN, 1,443,084 broker non-votes.

04-05-2026

BARK, Inc. (NYSE: BARK) announced the immediate appointment of James Gagne, a logistics executive with over 30 years of experience, to its Board of Directors. Mr. Gagne previously served as CEO of SEKO Logistics from 2017 to 2024, scaling the company from operations in three countries and $400M in revenue to 60 countries and $2.4B in revenue. CEO Matt Meeker praised Gagne's supply chain expertise as key to supporting BARK's operations.

• ·James Gagne holds a B.S. from the U.S. Merchant Marine Academy and speaks Mandarin Chinese.
• ·BARK was founded in 2011.
• ·Reference to Q4 FY26 10-Q filed February 5, 2026, for risk factors.

04-05-2026

New Mountain Finance Corp reported stable adjusted net investment income of $32.2 million or $0.32 per share for Q1 2026, flat YoY, amid portfolio enhancements and a ~$470 million Secondary Sale completed on March 10, 2026. However, NAV per share declined to $10.92 from $11.52 at December 31, 2025, reflecting the sale, market movements in software loans, and net realized/unrealized losses leading to a $(0.51) per share loss from operations versus $0.22 profit in Q1 2025. The company repurchased ~$66 million of shares YTD at $8.01 average, announced $50 million additional repurchase authorization (remaining capacity ~$80 million), and reduced debt cost on Holdings Credit Facility.

• ·Portfolio composition: 64.7% First Lien, 16.6% Senior Loan Funds (SLP III & IV) & NMNLC, 19.7% other.
• ·91.4% of portfolio fair value rated Green on internal Risk Rating as of March 31, 2026.
• ·Weighted average YTM at Cost of 11.1% as of March 31, 2026.
• ·Reduced cost of debt from SOFR + 1.95% to SOFR + 1.85% on Holdings Credit Facility.
• ·$692.1 million available capacity on credit facilities as of March 31, 2026.
• ·Q2 2026 distribution of $0.25 per share payable June 30, 2026 to holders of record June 16, 2026.

04-05-2026

Viatris Inc. announced that Chief Financial Officer Theodora 'Doretta' Mistras will depart for a new opportunity, remaining with the company until May 22, 2026, while Paul Campbell, current Chief Accounting Officer and Corporate Controller, is named Interim CFO effective May 8, 2026. CEO Scott A. Smith thanked Mistras for her contributions toward sustainable growth and expressed confidence in Campbell's expertise to ensure continuity and operational discipline. The company plans to release Q1 2026 financial results on May 7, 2026, with a conference call at 8:30 a.m. ET.

• ·Campbell joined Viatris' legacy company Mylan in 2002 and brings over two decades of experience.
• ·Campbell previously served nearly a decade at Deloitte & Touche as a Senior Manager in Audit.
• ·Campbell holds a Bachelor of Science in Accounting from Pennsylvania State University.

04-05-2026

Pool Corporation announced a leadership transition effective May 4, 2026, appointing John B. Watwood as President and CEO, succeeding Peter D. Arvan who is stepping down from those roles and the Board after nine years; John E. Stokely was appointed Executive Chair. The company reaffirmed its full-year 2026 guidance as previously provided on April 23, 2026, but postponed its Investor Day originally scheduled for May 12, 2026. No changes to strategic priorities or operations were indicated.

• ·John B. Watwood joined POOLCORP as Executive Vice President in January 2026.
• ·Peter D. Arvan served in his roles for nine years.
• ·John E. Stokely has served on the Board since 2000, as Lead Independent Director since 2003, and as Chair since 2017.

04-05-2026

PSQ Holdings, Inc. entered into a Severance Agreement and General Release with James Rinn, effective April 30, 2026, as disclosed in this 8-K filing under Item 5.02. The agreement is attached as Exhibit 10.1. The report was signed by Jim Giudice, Chief Legal Officer, on May 4, 2026.

• ·XBRL identifiers include Class A Common Stock (par value $0.0001 per share) and Redeemable Warrants (exercisable at $11.50 per share)
• ·Event dated April 29, 2026 in XBRL tags

04-05-2026

CooperCompanies (Nasdaq: COO) announced the appointment of Paul Keel as an independent director effective July 1, 2026, with membership on the Audit Committee. Chair Colleen Jay highlighted Keel's CEO experience at Envista Holdings Corporation and Smiths Group plc, along with prior leadership at 3M, as valuable for executing strategy and creating shareholder value. The company, with over 15,000 employees, operates CooperVision and CooperSurgical businesses globally.

• ·Paul Keel previously served as CEO of Envista since 2024, CEO of Smiths Group from 2021-2024, and held multiple leadership roles at 3M over 16 years.
• ·Mr. Keel holds an MBA from Harvard Business School and a BA in Economics from Carleton College.
• ·Headquartered in San Ramon, CA; contact: Kim Duncan at 925-460-3663 or ir@cooperco.com

04-05-2026

On April 28, 2026, JFB Construction Holdings, upon recommendation of its Compensation Committee and approval by the Board, awarded 100,000 shares of Class A common stock to CFO Ruben Calderon as a transaction achievement bonus linked to the February 13, 2026 Agreement and Plan of Merger with XTEND Reality Expansion Ltd. The shares were issued on April 30, 2026, under the 2024 equity incentive plan. No other performance metrics or changes in officer status were disclosed.

• ·Merger agreement dated February 13, 2026
• ·Shares have par value of $0.0001
• ·Registrant is an emerging growth company
• ·Securities: Class A Common Stock, $0.0001 par value, traded as JFB on Nasdaq

04-05-2026

Block, Inc. appointed Andrea Acosta as Chief Accounting Officer (principal accounting officer) effective May 26, 2026, succeeding Amrita Ahuja, who served as interim and will continue as CFO and COO. Acosta, formerly CAO at Pinterest, Inc., will report to Ahuja and receive $550,000 annual base salary, $250,000 sign-on bonus, and $8.0 million in RSUs vesting over four years. No family relationships or conflicting interests were disclosed.

• ·Andrea Acosta, age 47, previously served as Chief Accounting Officer at Pinterest since February 2022, Global Controller and Chief Accounting Officer at BioMarin from July 2020 to February 2022, and various finance roles at Levi Strauss & Co. from 2007 to 2017.
• ·Sign-on bonus subject to reimbursement if Ms. Acosta voluntarily terminates within two years of start date.
• ·Ms. Acosta holds a B.S. in Accounting from San Francisco State University.
• ·No family relationships between Ms. Acosta and any director or officer; no arrangements or understandings regarding appointment; no material interests under Item 404(a) of Regulation S-K.

04-05-2026

Publix Super Markets announced Executive Chairman Todd Jones' intent to retire effective May 31, 2026, while he will continue as chairman of the board of directors. CEO Kevin Murphy commended Jones' 46-year career, leadership, and contributions including championing food donation campaigns that reached 1 billion pounds donated in 2025. Publix, the largest U.S. employee-owned company with over 260,000 associates and 1,434 stores across eight states, expressed confidence in its ongoing leadership and mission.

• ·Jones began career in 1980 as a front-service clerk; promoted to store manager (1988), district manager (1997), regional director (1999), VP Jacksonville Division (2003), SVP product business development (2005), president (2008), CEO and President (2016), CEO (2019), Executive Chairman (2024).
• ·Received George W. Jenkins Award for Excellence in 1994.
• ·Jones serves on boards of Florida Council of 100 and Fish and Wildlife Foundation of Florida; former FMI board member; inducted into Tampa Bay Business Hall of Fame.
• ·Publix operates stores in Florida, Georgia, Alabama, Tennessee, South Carolina, North Carolina, Virginia, and Kentucky.
• ·Recognized by Fortune as a great place to work for 29 consecutive years.

04-05-2026

Edwards Lifesciences Corporation announced the appointment of Theodora (“Doretta”) Mistras as corporate vice president and chief financial officer (CFO), effective at the end of May 2026, succeeding Scott Ullem who has served as CFO since 2014 and announced his planned transition in October. Mistras joins from Viatris, where she has been CFO since March 2024, with prior senior roles in healthcare investment banking at Citigroup Global Markets and Goldman Sachs. CEO Bernard Zovighian highlighted her experience as instrumental for executing the company's strategy and delivering long-term value.

• ·Mistras holds a bachelor’s degree in international studies from the University of Pennsylvania and a bachelor’s degree in economics from the Wharton School.
• ·Ullem will continue as a strategic advisor in the months ahead.

04-05-2026

On April 28, 2026, Streamex Corp. appointed Mitchell Young Williams, its Chief Investment Officer, as a non-independent director effective immediately. The company entered into amended employment agreements effective April 6 or May 1, 2026, with Williams, CEO Karl Henry McPhie, and Interim Executive Chairman Morgan Lekstrom, each providing a $350,000 annual base salary, minimum $100,000 bonus for 2026, substantial RSU/PSU grants (up to 2.25M units per executive tied to GLDY sales milestones reaching $3B cumulative and market cap targets up to $500B), and severance protections including 12 months salary continuation.

• ·All amended agreements include 12 months salary severance, prorated bonus, and full equity vesting acceleration upon termination without cause, good reason resignation, change in control, or protected termination.
• ·PSU vesting subject to continuous employment and certified cumulative GLDY sales; unvested tranches forfeit after 10th anniversary of effective dates.
• ·Market cap bonuses based on 30-day VWAP and subject to equity plan limits.

04-05-2026

D-Wave Quantum Inc. entered into the Third Amendment to the Amended and Restated Employment Agreement with President and CEO Dr. Alan Baratz on April 30, 2026, increasing his annual base salary to $700,000 effective January 1, 2026, and granting him restricted stock units valued at $13,488,000 under the 2022 Equity Incentive Plan. The Board approved these changes in recognition of Dr. Baratz’s years of service and commitment to the Company. No departures or elections of officers or directors were reported.

• ·Third Amendment references original Amended and Restated Employment Agreement dated January 1, 2020
• ·Amendment filed as Exhibit 10.1

04-05-2026

Pasithea Therapeutics Corp. (NASDAQ: KTTA) announced the appointment of Kartik Krishnan, M.D., Ph.D., as Chief Medical Officer effective May 1, 2026, to oversee clinical development of PAS-004, a next-generation macrocyclic MEK inhibitor for NF1-associated neurofibromas and other indications. Dr. Krishnan brings over 20 years of experience, including contributions to the FDA approval of cobimetinib at Genentech. The appointment strengthens leadership as PAS-004 advances in Phase 1 (NCT06299839) and Phase 1/1b (NCT06961565) trials.

• ·Dr. Krishnan previously served as CEO at OncoNano Medicines and CMO at Arcus Biosciences.
• ·At Genentech, contributed to cobimetinib approvals: 2015 for BRAF-mutant melanoma with vemurafenib, and 2022 for Langerhans cell histiocytosis.
• ·Dr. Krishnan's education: B.A. from University of Virginia, M.D./Ph.D. from Columbia University, training at UCLA, Johns Hopkins, and National Cancer Institute.

04-05-2026

Ducommun Incorporated (NYSE: DCO) appointed Mark A. Caylor, former Corporate Vice President and President of Northrop Grumman’s Mission Systems Sector, as an independent director effective May 4, 2026, to support its VISION 2027 Strategy. This marks the addition of 6 new directors in the past 5 years as part of an ongoing board refreshment process. Caylor brings over 35 years of aerospace and defense experience, including strategy and M&A leadership.

• ·Mark A. Caylor has served as a director on LightPath Technologies since October 2025 and retired from Northrop Grumman in 2024.
• ·Caylor holds degrees from MIT (bachelor’s in aeronautical and astronautical engineering), Caltech (master’s in aeronautics and astronautics), and UCLA Anderson (MBA).

04-05-2026

Johnson Controls International plc announced on May 1, 2026, that Lei Schlitz, Vice President and President, Global Products & Solutions, will depart as part of a planned transition tied to changes in the company's operating model, with her service continuing through October 1, 2026. She will receive severance benefits under the Severance and Change in Control Policy for Officers. No successor has been named, and the change reflects a revised scope for her position.

• ·Severance benefits described in Exhibit 10.6 to the Form 10-K for fiscal year ended September 30, 2025.

04-05-2026

On April 13, 2026, Irving Minnaker resigned from the Board of Directors of Cycurion, Inc. and from any offices he held, effective February 14, 2026. The resignation was not the result of any disagreement with the company's operations, policies, or practices. The company thanked Mr. Minnaker for his service and contributions.

• ·Form 8-K filed on May 4, 2026
• ·Registrant is an emerging growth company

04-05-2026

Occidental Petroleum (NYSE: OXY) announced CEO succession as part of management planning: Vicki Hollub will retire as President and CEO effective June 1, 2026, with Senior Vice President and Chief Operating Officer Richard Jackson named as her successor. Hollub, CEO since 2016, will continue on the Board for continuity, while Jackson will join the Board on the same date. The leadership praised the company's strong portfolio and technical expertise post-transformation.

• ·Announcement dated May 1, 2026; filing dated May 04, 2026.
• ·Jackson joined Occidental in 2003; prior roles include President of U.S. Onshore Oil and Gas and President of Low Carbon Integrated Technologies.
• ·Hollub has over 40 years at Occidental; Board member since 2015.
• ·Media contact: Eric Moses (713-497-2017); Investor contact: Babatunde A. Cole (713-552-8811).

04-05-2026

Hawkeye Systems, Inc. appointed four new directors—Martin Sumichrast, Sim Farar, Nathan Bradley Fleisher, and Ralph Olson—effective May 4, 2026, expanding the Board from one to five members pursuant to an Investor Rights Agreement with Steve Hall and Hawkeye Holdco LLC, bringing extensive experience in finance, capital formation, investment banking, and public company governance. The new directors' backgrounds include leading companies that raised hundreds of millions in capital and achieved significant market caps and sales. However, Martin Sumichrast was subject to a 2024 SEC judgment requiring $350,000 in disgorgement, interest, and penalties, and the company was downgraded from OTCQB Venture Market to OTC Pink Limited Market effective April 29, 2026, due to a recent change in control.

• ·Company filed Schedule 14f-1 on April 16, 2026, and completed mailing on April 24, 2026.
• ·Investor Rights Agreement entered on April 1, 2026.
• ·SEC judgment against Martin Sumichrast entered April 29, 2024, in U.S. District Court for Western District of North Carolina.
• ·Company's application to OTCID Basic Market approved.
• ·Company endeavors to become a leading private equity and corporate advisory firm in crypto and frontier financial services verticals.

04-05-2026

VisionWave Holdings, Inc. appointed Atara Dzikowski, a current Board member, as Vice President of Mergers and Acquisitions effective May 1, 2026, with an employment agreement providing a $240,000 annual base salary and 500,000 shares of common stock or RSUs (150,000 vesting immediately). Ms. Dzikowski resigned from the Audit, Compensation, and Nominating and Governance Committees on April 22, 2026, with Daniel Ollech, Mansour Khatib, and Judit Nagypal appointed to fill those roles, maintaining Nasdaq compliance. The equity includes performance-based vesting tied to cumulative revenue milestones of $5M, $10M, $15M, and $17.5M.

• ·Employment agreement initial term of three years from April 1, 2026, with automatic renewals.
• ·Severance upon termination without cause or for good reason equals one year of base salary, payable within six months post-release.
• ·No family relationships or disagreements disclosed regarding transitions.
• ·Exhibits include Employment Agreement (10.1), Restrictive Covenant Agreement (10.2), and Arbitration Agreement (10.3).

04-05-2026

Navitas Semiconductor (Nasdaq: NVTS) appointed semiconductor veteran Davin Lee as Independent Director to its Board effective May 4, 2026, filling an open position as part of its board refreshment process initiated last year. Lee, with over 30 years of experience from companies like Renesas, Dialog Semiconductor, and Intersil, will serve on the Compensation Committee and Governance and Sustainability Committee, and stand for reelection in 2027 as a Class III director. The appointment supports Navitas' strategic pivot to high-power markets in AI data centers, energy infrastructure, and industrial electrification using GaNFast GaN and GeneSiC SiC technologies.

• ·Board intends to reduce size to eight directors at 2027 annual meeting
• ·Lee earned B.S. in Electrical Engineering from University of Texas at Austin and M.B.A. from Kellogg School of Management at Northwestern University
• ·Navitas is the world’s first semiconductor company to be CarbonNeutral-certified

04-05-2026

Agilent Technologies, Inc. (NYSE: A) appointed Michael Buckner as Chief Legal Officer effective May 4, 2026, bringing nearly three decades of global legal experience from Danaher Corp., General Electric, and others, with expertise in M&A, governance, and regulatory matters. Padraig McDonnell, president and CEO, highlighted Buckner's role in advancing strategy. The company reported fiscal year 2025 revenue of $6.95 billion and employs approximately 18,000 people worldwide.

• ·Buckner previously served as VP, Deputy General Counsel, and Chief M&A Counsel at Danaher, leading legal strategy for Abcam acquisition and Veralto spin-off.
• ·Buckner holds a BA from Rutgers University and JD from University of Chicago Law School.

04-05-2026

At the Annual Meeting on May 1, 2026, AMN Healthcare Services, Inc. shareholders elected nine directors to the Board, approved Amendment No. 1 to the AMN Healthcare 2025 Equity Plan, ratified KPMG LLP as the independent auditor for the fiscal year ending December 31, 2026, and approved executive compensation on an advisory basis. However, the shareholder proposal for an Independent Board Chairman failed overwhelmingly, receiving 7,495,013 votes in favor versus 22,327,804 against. All directors received majority support, but Sylvia D. Trent-Adams faced the highest opposition with 2,121,512 votes against.

• ·Proposal 1 (Director Elections): Broker non-votes 4,410,527 across all.
• ·Proposal 2 (Say-on-Pay): 22,728,186 For, 7,071,111 Against, 40,119 Abstain.
• ·Proposal 3 (Auditor Ratification): 33,170,877 For, 1,064,827 Against, 14,239 Abstain.
• ·Proposal 4 (Equity Plan Amendment): 28,909,689 For, 895,750 Against, 33,977 Abstain.
• ·Proposal 5 (Independent Board Chairman): 7,495,013 For, 22,327,804 Against, 16,599 Abstain.

04-05-2026

On May 1, 2026, Imunon, Inc. entered into Change in Control Agreements, approved by the Compensation Committee, with CEO and President Stacy Lindborg, Chief Medical Officer Douglas Faller, and General Counsel and Corporate Secretary Susan Eylward. These agreements provide lump-sum severance of 2.5 times (Lindborg) or 1.5 times (others) the sum of annual base salary and target bonus upon qualifying terminations without cause or for good reason around a change of control. Additional benefits include up to 24 months (Lindborg) or 18 months (others) of health and life insurance premium coverage and full acceleration of outstanding equity awards.

• ·Severance payable if termination without cause or for good reason within one year after or four months prior to change in control.
• ·Equity awards fully accelerate; options exercisable for remainder of original term or up to 18 months post-vesting.
• ·Benefits subject to execution of release of claims; greater of CIC or other agreement benefits applies.
• ·Form of agreement attached as Exhibit 10.1.

04-05-2026

Trex Company, Inc. appointed Zachary C. Lauer as Senior Vice President, Chief Operations Officer, promoting him from his prior role as Senior Vice President, Supply Chain and Manufacturing after 10 years with the company. Lauer brings over two decades of operations, supply chain, and manufacturing experience, and will lead manufacturing, supply chain, engineering, and R&D functions. The announcement underscores Trex's position as the world’s largest manufacturer of wood-alternative composite decking and railing, with products sold through more than 6,700 retail outlets across six continents.

• ·Trex named on Barron’s list of 100 Most Sustainable U.S. Companies (2024 and 2025).
• ·Trex named one of America’s Most Responsible Companies 2024 by Newsweek.
• ·Trex ranked as one of 100 Best ESG Companies by Investor’s Business Daily.

04-05-2026

At The Williams Companies, Inc.'s 2026 Annual Meeting on April 28, 2026, stockholders elected ten director nominees with strong support (91-97% votes in favor), approved advisory say-on-pay for named executive officers (95% for), ratified Ernst & Young LLP as auditors (99% for), and approved amendments to the 2007 Incentive Plan (increasing issuable shares from 50,000,000 to 85,000,000) and 2007 Employee Stock Purchase Plan (from 5,200,000 to 7,200,000 shares). All proposals passed overwhelmingly with no significant opposition. No stockholder questions were received.

• ·Director with lowest support: Stephen W. Bergstrom (930,781,739 for; 55,362,318 against; 696,707 abstentions).
• ·Director with highest support: Chad J. Zamarin (970,347,236 for; 15,789,776 against; 703,752 abstentions).
• ·Say-on-pay: 954,373,556 for; 29,628,316 against; 2,838,892 abstentions.
• ·Auditor ratification: 1,034,329,205 for; 64,449,935 against; 727,973 abstentions (no broker non-votes).

04-05-2026

Community Trust Bancorp, Inc. announced the planned retirement of Richard W. Newsom, its Executive Vice President and President of Community Trust Bank, Inc., effective February 5, 2027, following his notification on April 29, 2026. Mr. Newsom will continue serving in his roles until retirement. The company, with $6.7 billion in assets, is headquartered in Pikeville, Kentucky, and operates 69 banking locations across parts of Kentucky, six in southern West Virginia, three in northeastern Tennessee, four trust offices in Kentucky, and one in Tennessee.

• ·Notification date: April 29, 2026
• ·Retirement effective date: February 5, 2027
• ·Contact for additional information: Mark A. Gooch at (606) 437-3229

04-05-2026

At the Globe Life Inc. Annual Meeting of Shareholders on April 30, 2026, Linda L. Addison and Marilyn A. Alexander retired from the Board of Directors, while shareholders elected 12 new directors, with most nominees receiving strong support (e.g., over 62 million For votes for several) but notable opposition for J. Matthew Darden (3,011,568 Against), Frank M. Svoboda (3,016,248 Against), and Mark A. Blinn (2,102,849 Against). Proposal II (say-on-pay) passed with 55,385,745 For versus 6,887,045 Against, Proposal III (2026 Incentive Plan) with 57,917,710 For versus 4,271,772 Against, and Proposal IV (auditor ratification) overwhelmingly with 67,622,465 For versus 3,212,321 Against. Broker non-votes totaled 8,517,316 across director elections and compensation proposals.

• ·Shareholder vote on executive compensation frequency to occur in 2029 proxy materials.
• ·Annual Meeting held April 30, 2026; Form 8-K filed May 4, 2026.

04-05-2026

At the Annual Meeting on May 1, 2026, stockholders elected seven directors to the Board with overwhelming support (generally over 90% FOR votes), approved the Third Amended and Restated 2017 Incentive Award Plan increasing available shares by 1.5 million and extending to 2036, ratified Ernst & Young LLP as auditors nearly unanimously, and approved executive compensation (67% FOR with 11 million AGAINST votes). On May 4, 2026, CEO David Schaeffer was granted 1,000,000 restricted shares (2026 CEO Performance Award) in three tranches vesting over five years upon achieving VWAP targets of $70 (200,000 shares), $85 (300,000 shares), and $100 (500,000 shares). All proposals passed, reflecting strong overall shareholder approval despite some opposition to executive pay.

• ·Annual Meeting held May 1, 2026, at 2450 N Street NW, Washington, DC 20037.
• ·Detailed voting: Plan (FOR: 25,506,567; AGAINST: 8,664,157; ABSTAIN: 124,722); Exec comp (FOR: 23,028,277; AGAINST: 11,056,995; ABSTAIN: 210,174); Auditors (FOR: 38,382,379; AGAINST: 253,556; ABSTAIN: 100,229).
• ·CEO award term: 5 years from February 28, 2026, to February 28, 2031; requires continuous service as CEO through Dec 31, 2028 and CEO or approved role thereafter.
• ·Provisions for change in control, death, or disability allow pro-rata vesting based on achieved stock price.

04-05-2026

Adeia Inc. announced that CEO Paul E. Davis intends to step down by Q4 2026 to focus on health and personal pursuits, remaining in role until a successor is named, with the Board launching a search led by Chairman Dan Moloney. During Davis's tenure, the company grew its patent portfolio by over 35%, increased non-Pay-TV recurring revenue by over 60%, reduced debt by nearly 50%, and delivered record revenue and earnings in 2025. While positioned for growth in media and semiconductors, the leadership transition introduces potential uncertainty.

• ·Davis joined predecessor in 2011 as associate general counsel, became general counsel within 2 years.
• ·Appointed president and CEO in May 2022 following separation from Xperi in October 2022.
• ·Nearly 15 years total tenure including predecessors.

04-05-2026

Pinterest reported Q1 2026 revenue of $1,008 million, up 18% YoY (15% constant currency), with record global MAUs of 631 million, up 11% YoY, and completed approximately $2 billion in share repurchases. However, GAAP net loss widened to $74 million from a $9 million profit YoY, net cash from operating activities declined 10% to $328 million, and free cash flow fell 13% to $312 million. Q2 2026 guidance projects revenue of $1,133-1,153 million (14-16% YoY growth) and Adjusted EBITDA of $256-276 million.

• ·U.S. and Canada MAUs grew 4% YoY to 106 million (flat performance).
• ·Europe revenue up 27% YoY to $186 million; Rest of World up 59% to $72 million.
• ·Global ARPU increased 6% YoY to $1.61.
• ·Q2 2026 revenue guidance assumes ~1 point FX tailwind.